[1]
M. Karaźniewicz-Łada, D. Danielak, P. Burchardt, and F. Główka, “The influence of diabetic status on the pharmacokinetics of clopidogrel and its metabolites in patients suffered from cardiovascular diseases”, JMS, vol. 83, no. 3, pp. 215–221, Sep. 2014.